Forbright, Inc. (VACH) Stock

Forbright, Inc. (VACH) is a Financials stock trading at $18.73 (as of 2026-08-21), with a market capitalization of $562.48M and a trailing P/E of 136.5. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Valuation — source: SEC EDGAR (first-party)
Price$18.73
Market Cap$562.48M
P/E Ratio136.5
EV / EBITDA-15.0
Price / Book0.58
Price / Sales4.36
FCF Yield-17.8%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$586.42M
Net Margin15.0%
Return on Equity0.4%
Revenue Growth (YoY)4.7%
FCF Growth (YoY)102.1%
Valuation vs Sector & Industry
Stock P/E136.5
Sector P/E (Financials)15.1
Industry P/E (Banking)13.0
vs Sector803.8%
vs Industry952.1%
Company
SectorFinancials
IndustryBanking

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

  • Editas Medicine, Inc. (EDIT)
  • Ocugen, Inc. (OCGN)
  • Ginkgo Bioworks Holdings, Inc. (DNA)
  • Compass Therapeutics, Inc. (CMPX)
  • Lexeo Therapeutics, Inc. Common Stock (LXEO)
  • Fennec Pharmaceuticals Inc. (FENC)
  • X4 Pharmaceuticals, Inc. (XFOR)
  • Palisade Bio, Inc. (PALI)
VACH earnings history · VACH institutional & insider holders · VACH KPIs & operating metrics · VACH financials · VACH investor presentations & press releases · VACH SEC filings · VACH peers · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-08-21.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.